CRYSVITA (burosumab-twza) is approved in the United States to treat XLH in adults and pediatric patients aged six months and older. Kyowa Kirin is also generating real-world evidence through the ...

There are several reasons patients with multiple myeloma may experience the electrolyte abnormality. A new literature review assessed the causes and consequences of hypophosphatemia in patients with ...

The pharmaceutical drug Injectafer (generic name: ferric carboxymaltose), an iron carbohydrate complex used to treat iron deficiency anemia, has been linked to severe hypophosphatemia (HPP) – a ...

Optimal cellular function is dependent on maintenance of a normal serum phosphorus concentration. Serum phosphorus concentration is affected by several determinants, the most important of which is ...

Hypophosphatemia refers to abnormally low levels of phosphate in the blood. Often, a person is unaware they have this condition and may not present with symptoms. This article explores ...

Hypophosphatemia is an abnormally low level of phosphate in the blood. It tends to develop in people with serious conditions like sepsis or diabetic ketoacidosis. It can also occur with alcohol use ...

Treatment goals include optimizing growth and functionality, increasing phosphate levels in the body, and managing pain. Treatments are ongoing, and include newer targeted therapies available for ...

X-linked hypophosphatemia is characterized by increased secretion of fibroblast growth factor 23 (FGF-23), which leads to hypophosphatemia and consequently rickets, osteomalacia, and skeletal ...

Nat Clin Pract Nephrol. 2006;2(3):136-148. Another musculoskeletal condition associated with hypophosphatemia is hypophosphatemic osteomalacia. Patients with this condition generally have proximal ...